Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schellens, J.H.
1110  Ergebnisse:
Personensuche X
?
1

PCN191 - COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS ..:

Vreman, R. ; van Nuland, M. ; ten Ham, R.M....
Value in Health.  21 (2018)  - p. S46 , 2018
Link: https://doi.org/10.1016/..
 
?
2

Dosing oxaliplatin in a haemodialysis patient with metastat..:

van Berlo - van de Laar, I. R. F. ; Brummelhuis, W. J. ; Imholz, A. L. T....
Journal of Clinical Pharmacy and Therapeutics.  43 (2018)  4 - p. 574-577 , 2018
Link: https://doi.org/10.1111/..
 
?
3

SPOT-003 Thymidylate synthase maintains the undifferentiate..:

Ceppi, P. ; Siddiqui, A. ; Gollavilli, P....
ESMO Open.  3 (2018)  - p. A17 , 2018
Link: https://doi.org/10.1136/..
 
?
4

Predicting clinical benefit from everolimus in patients wit..:

Weeber, Fleur ; Cirkel, Geert A. ; Hoogstraat, Marlous...
Oncotarget.  8 (2017)  33 - p. 55582-55592 , 2017
Link: https://doi.org/10.18632..
 
?
5

Selection of chemotherapy for hyperthermic intraperitoneal ..:

Braam, H.J. ; Schellens, J.H. ; Boot, H....
Critical Reviews in Oncology/Hematology.  95 (2015)  3 - p. 282-296 , 2015
Link: https://doi.org/10.1016/..
 
?
6

505 Clinical evidence of intra-tumoral immune activation an..:

Tabernero, J. ; Homicsko, K. ; Schellens, J.H....
European Journal of Cancer.  51 (2015)  - p. S104-S105 , 2015
Link: https://doi.org/10.1016/..
 
?
7

Time Dependent Resource Use and Costs Associated with Diffe..:

Frederix, G.W. ; Severens, J.L. ; Hövels, A.M....
Value in Health.  16 (2013)  7 - p. A578 , 2013
Link: https://doi.org/10.1016/..
 
?
8

MO2 Impact of Structural Assumptions on Cost-Effectiveness ..:

Frederix, G.W. ; Van hasselt, J.G. ; Schellens, J.H....
Value in Health.  15 (2012)  7 - p. A282-A283 , 2012
Link: https://doi.org/10.1016/..
 
?
9

PRM46 Development of a Framework for Cost-Effectiveness Ana..:

Frederix, G.W. ; van Hasselt, J.G. ; Severens, J.L....
Value in Health.  15 (2012)  7 - p. A468 , 2012
Link: https://doi.org/10.1016/..
 
?
10

651 DISCUSSION Pharmacodynamic evaluation of pCDC2 and Wee1..:

Cheng, J.D. ; Tibes, R. ; Schellens, J.H....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 203 , 2010
Link: https://doi.org/10.1016/..
 
?
11

644 POSTER The novel oral taxane BMS275183 has a favorable ..:

Bröker, L.E. ; Veltkamp, S. ; Heath, E....
European Journal of Cancer Supplements.  4 (2006)  12 - p. 194 , 2006
Link: https://doi.org/10.1016/..
 
?
12

A micromechanical approach to time-dependent failure in off..:

Govaert, L.E. ; Schellens, H.J. ; Thomassen, H.J.M....
Composites Part A: Applied Science and Manufacturing.  32 (2001)  12 - p. 1697-1711 , 2001
Link: https://doi.org/10.1016/..
 
?
13

Creep behaviour of Hybrid Composites Based on Polyethylene ..:

Peijs, A.A.J.M. ; Schellens, H.J. ; Govaert, L.E.
Advanced Composites Letters.  2 (1993)  6 - p. 096369359300200 , 1993
Link: https://doi.org/10.1177/..
 
?
14

Dabrafenib plus trametinib in patients with BRAF V600E-muta..:

Subbiah, V. ; Kreitman, R.J. ; Wainberg, Z.A....
Annals of Oncology.  33 (2022)  4 - p. 406-415 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Monitoring of EGFR mutations in circulating tumor DNA of no..:

Verheijen, R. B. ; van Duijl, T. T. ; van den Heuvel, M. M....
Cancer Chemotherapy and Pharmacology.  87 (2021)  2 - p. 269-276 , 2021
Link: https://doi.org/10.1007/..
 
1-15